Cleared Special

K010138 - PROFILE II ER (FDA 510(k) Clearance)

Feb 2001
Decision
28d
Days
Class 2
Risk

K010138 is an FDA 510(k) clearance for the PROFILE II ER. This device is classified as a Enzyme Immunoassay, Cannabinoids (Class II - Special Controls, product code LDJ).

Submitted by Medtox Diagnostics, Inc. (Burlington, US). The FDA issued a Cleared decision on February 14, 2001, 28 days after receiving the submission on January 17, 2001.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3870.

Submission Details

510(k) Number K010138 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 2001
Decision Date February 14, 2001
Days to Decision 28 days
Submission Type Special
Review Panel Toxicology (TX)
Summary Statement

Device Classification

Product Code LDJ — Enzyme Immunoassay, Cannabinoids
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3870

Similar Devices — LDJ Enzyme Immunoassay, Cannabinoids

Healgen® Accurate Oral Fluid Drug Test, Healgen® Accurate Oral Fluid Drug Test COT
K223162 · Healgen Scientific, LLC · Mar 2023
Immunalysis Cannabinoids Urine Enzyme Immunoassay, Immunalysis cTHC Urine Calibrators, Immunalysis cTHC Urine Control Set
K151203 · Immunalysis Corporation · Jun 2015
LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators and LZI Oral Fluid Cannabinoids Controls
K141320 · Lin-Zhi International, Inc. · May 2015